STAAR SURGICAL CO Earnings Per Share Disclosure
Note 16 — Basic and Diluted Net Income (Loss) Per Share
The following table sets forth the computation of basic and diluted net income (loss) per share (in thousands except per share amounts):
|
|
Years Ended |
|
|||||||||
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
Numerator: |
|
|
|
|
|
|
|
|
|
|||
Net income (loss) |
|
$ |
(80,448 |
) |
|
$ |
(20,208 |
) |
|
$ |
21,347 |
|
Denominator: |
|
|
|
|
|
|
|
|
|
|||
Weighted average common shares outstanding |
|
|
49,568 |
|
|
|
49,125 |
|
|
|
48,523 |
|
Weighted average common shares outstanding for basic |
|
|
49,568 |
|
|
|
49,125 |
|
|
|
48,523 |
|
Dilutive potential common stock outstanding: |
|
|
|
|
|
|
|
|
|
|||
Stock options |
|
|
— |
|
|
|
— |
|
|
|
813 |
|
Unvested restricted stock |
|
|
— |
|
|
|
— |
|
|
|
3 |
|
RSUs |
|
|
— |
|
|
|
— |
|
|
|
56 |
|
PSUs |
|
|
— |
|
|
|
— |
|
|
|
32 |
|
Weighted average common shares outstanding for diluted |
|
|
49,568 |
|
|
|
49,125 |
|
|
|
49,427 |
|
Net income (loss) per share: |
|
|
|
|
|
|
|
|
|
|||
Basic |
|
$ |
(1.62 |
) |
|
$ |
(0.41 |
) |
|
$ |
0.44 |
|
Diluted |
|
$ |
(1.62 |
) |
|
$ |
(0.41 |
) |
|
$ |
0.43 |
|
Because the Company had a net loss for 2025 and 2024, the number of diluted shares is equal to the number of basic shares. The following table sets forth (in thousands) the weighted average number of options to purchase shares of common stock, restricted stock, RSUs and PSUs with either exercise prices or unrecognized compensation cost per share greater than the average market price per share of the Company’s common stock, which were not included in the calculation of diluted per share amounts because the effects would be anti-dilutive.
|
|
Years Ended |
|
|||||||||
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
Stock options |
|
|
5,253 |
|
|
|
4,166 |
|
|
|
2,073 |
|
Restricted stock, RSUs and PSUs |
|
|
778 |
|
|
|
212 |
|
|
|
32 |
|
Total |
|
|
6,031 |
|
|
|
4,378 |
|
|
|
2,105 |
|
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2026 | Mar 3, 2026 | Showing above |
| 2024 | Feb 21, 2025 | |
| 2023 | Feb 27, 2024 | |
| 2022 | Feb 23, 2023 | |
| 2021 | Feb 24, 2021 | |
| 2020 | Feb 26, 2020 | |
| 2018 | Feb 21, 2019 | |
| 2017 | Feb 28, 2018 | |
| 2016 | Mar 2, 2017 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.